NCT01661621View on ClinicalTrials.gov

Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1

PHASE4CompletedINTERVENTIONAL
Enrollment

395

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Bladder Outlet Obstruction
Interventions
DRUG

Detrusitol 4 mg QD

Group 1

DRUG

Doxazosin 4 mg QD

Group 2

Trial Locations (1)

970

Buddhist Tzu Chi General Hospital, Hualien City

All Listed Sponsors
lead

Buddhist Tzu Chi General Hospital

OTHER

NCT01661621 - Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1 | Biotech Hunter | Biotech Hunter